Samsung in Talks to Buy Alzheimer's Drug Maker for $42 Billion: Report

Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).

from NDTV Gadgets - Latest https://ift.tt/3Jtfszt
via